Blau Farmacêutica S.A. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was BRL 364.31 million compared to BRL 365.24 million a year ago. Net income was BRL 70.79 million compared to BRL 112.4 million a year ago. Basic earnings per share from continuing operations was BRL 0.4 compared to BRL 0.63 a year ago. Diluted earnings per share from continuing operations was BRL 0.4 compared to BRL 0.63 a year ago.
For the six months, sales was BRL 622.51 million compared to BRL 678.58 million a year ago. Net income was BRL 122.74 million compared to BRL 173.86 million a year ago. Basic earnings per share from continuing operations was BRL 0.69 compared to BRL 0.97 a year ago. Diluted earnings per share from continuing operations was BRL 0.69 compared to BRL 0.97 a year ago.